Calamos Advisors’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Calamos Advisors’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,000	Closed	-$261K	–	1169
2023 Q1	$261K	Hold	25,000	–	–	﹤0.01%	879
2022 Q4	$257K	Hold	25,000	–	–	﹤0.01%	938
2022 Q3	$251K	Buy	+25,000	New	+$251K	﹤0.01%	1046

Calamos Advisors's LVAC Position: Q2 2023 in Review

Calamos Advisors sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 25,000 shares — an estimated $261K sold.

Calamos Advisors first reported a position in LVAC in Q3 2022 and held it in 3 quarters. The position peaked at $261K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Calamos Advisors reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Calamos Advisors sold 25,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $261K.
Calamos Advisors first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 3 quarters.
Calamos Advisors's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $261K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Calamos Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.